Form 4 for HCA HCA Healthcare
Accepted 2026-02-12 00:00:00 ET · period of report 2026-02-10 · accession 0001193125-26-049184 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-12 | 2026-02-10 | HCA | Berres Jennifer | SVP, Chief Human Res. Off | A - Grant | $0.00 | +7,116 | 22.5K | +46% | $0 | |
| M | 2026-02-12 | 2026-02-11 | HCA | Berres Jennifer | SVP, Chief Human Res. Off | S - Sale | $514.58 | -8,020 | 16.0K | -33% | -$4.13M |
| 2026-02-12 | 2026-02-10 | HCA | Berres Jennifer | SVP, Chief Human Res. Off | F - Tax | $502.05 | -2,515 | 20.0K | -11% | -$1.26M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-10 | A | A | 7,116 | $0.00 | 22,528 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-11 | S | D | 4,010 | $526.16 | 11,993 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $525.97to $526.3101, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2026-02-11 | S | D | 4,010 | $503.00 | 16,003 | D | — | — | |
| 4 | Common | Common Stock | 2026-02-10 | F | D | 2,515 | $502.05 | 20,013 | D | — | — |